Mimedx (MDXG) Other Non-Current Liabilities (2011 - 2026)

Mimedx has disclosed Other Non-Current Liabilities across 16 years of filings, most recently posting $5.1 million for Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $5.1 million, down 31.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.1 million (down 31.98% YoY), and the FY2025 annual result was $5.4 million, down 27.24% from the prior year.
• Other Non-Current Liabilities came in at $5.1 million for Q1 2026 at Mimedx, down from $5.4 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $7.5 million in Q1 2025 to a low of $2.2 million in Q4 2023.
• The 5-year median for Other Non-Current Liabilities is $4.8 million (2022), against an average of $4.8 million.
• Across the five-year window, Other Non-Current Liabilities plunged 53.43% in 2023 and surged 232.12% in 2024, its largest moves.
• Mimedx's Other Non-Current Liabilities stood at $4.8 million in 2022, then slumped by 53.43% to $2.2 million in 2023, then soared by 232.12% to $7.4 million in 2024, then fell by 27.24% to $5.4 million in 2025, then dropped by 5.14% to $5.1 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $5.1 million (Q1 2026), $5.4 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.